/Investor DB

Palisades Growth Capital — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

AiCureaicure.comin𝕏Nov 2019 · $24.5M

AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Sabina Chadha(Chief Executive Officer)inAnand Ramaswamy(Chief Product Officer)inJun Lu(VP of Engineering and AI)in

Co-investorsVIVE VCAccelmed PartnersAsahi Kasei Corporate Venture CapitalTribeca Venture PartnersBaird CapitalNew Leaf Venture Partners+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.